Paradigm

Company profile

About Paradigm

Paradigm Health is transforming clinical trial execution through an AI-native platform that integrates directly with healthcare provider systems and workflows. The company addresses critical inefficiencies in drug development, where 50% of trials fail to meet enrollment targets and the average drug takes 12+ years to reach market at a cost exceeding $2.6 billion. Paradigm Health's end-to-end solution serves both trial sponsors and research sites, offering protocol optimization, feasibility analysis, site selection, patient identification, enrollment acceleration, and automated data capture. The platform leverages real-time EHR data and AI-powered screening to identify eligible patients within provider workflows, supported by experienced clinical research coordinators. For sponsors, Paradigm Health delivers faster study startup, stronger enrollment performance, and higher-quality data through eSource-powered sites and automated data workflows. For providers, the platform simplifies research conduct by reducing administrative burden and enabling seamless integration with existing care delivery. The company operates a network of over 100 research sites across the United States, Japan, and Israel, partnering with community healthcare providers and academic medical centers. Paradigm Health supports Phase I-IV clinical trials, including interventional, observational, and pragmatic studies, with particular strength in oncology and rare disease research. The company's approach has demonstrated measurable outcomes, including 6.5x faster enrollment in multiple myeloma trials and 45% increased enrollment at partner sites like Highlands Oncology.

Company description · Paradigm official website